GILD

Market Closed

Gilead Sciences Inc

$124.91

$0.03 (-0.02%)

Sabtu, 17 Januari 2026 06:17 WIB

$124.94

$3.66 (3.02%)

Sabtu, 17 Januari 2026 03:59 WIB

150.46 B

Market Cap

Performa Harga

Harga kembali 1 minggu3.09%

Harga kembali 1 Bulan5.21%

Harga kembali 3 Bulan6.01%

Harga kembali 6 Bulan13.73%

Harga Tertinggi (52 Minggu)128.67

Harga Terendah (52 Minggu)91.79

Latar Belakang Perusahaan

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

Summary

Valuation Information

Current PE Ratio (TTM)19.34

Forward PE Ratio13.79

Current Price to Book Value7.2

Current Price to Sales5.35

EV to Revenue5.78

EV to EBITDA12.29

PEG Ratio0.13

Per Share

Current EPS (Annualized)6.46

Diluted EPS (TTM)6.46

Revenue Per Share23.35

Current Book Value Per Share17.34

Dividend

Dividend Per Share3.14

Dividend Yield0.0253

Ex Dividend Date2025-12-15

Dividend Payment Date2025-12-30

Income Statement

EBITDA14136001000

Profit Margin0.279

Operating Margin0.452

Feed

Berita

Broker Summary

Technical

Finansial

Laporan

Profil

Loading feeds...